摘要
微小病变肾病(minimal change disease,MCD)又称类脂性肾病,是导致肾病综合征的最常见病理类型之一,对激素敏感但极易复发,反复发作后可能对激素依赖或耐药,从而影响预后。MCD属中医学"水肿""尿浊""腰痛""癃闭"之范畴,其发病与肺、脾、肾三脏功能失调有关。在治疗MCD方面,杨霓芝教授有着深厚的造诣,使用中医药改善MCD患者中大量蛋白尿、低蛋白血症、高度水肿的临床症状有一定疗效,配合激素治疗,可减轻药物副作用,提高疗效,降低复发率和不良反应发生率。
Minimal change disease(MCD),also known as lipid-induced nephropathy,is one of the most common pathological types of nephrotic syndrome.It is sensitive to hormones but is highly recurrent.It may be hormonedependent or resistant after repeated episodes,Influencing prognosis.MCD belongs to the category of"edema""urine turbidity""low back pain"and"stagnation"in Chinese medicine.Its pathogenesis is related to the dysfunction of lung,spleen and kidney.Professor Yang Nizhi has a profound knowledge in the treatment of MCD.The use of traditional Chinese medicine to improve the clinical symptoms of massive proteinuria,hypoproteinemia and high edema in MCD patients has a certain effect.With hormone therapy,it can reduce the side effects of drugs and improve the curative effect.Reduce the rate of recurrence and the incidence of adverse reactions.
作者
吴东明
谈平
董金莉
曾翠青
杨霓芝
Wu Dongming;Tan Ping;Dong Jinli;Zeng Cuiqing;Yang Nizhi(Hainan hospital of traditional Chinese medicine Nephrorheumatology,Haikou 570203,China;Guangdong Provincial Hospital of Chinese Medicine Nephrology,Guangzhou 510120,China)
出处
《世界科学技术-中医药现代化》
CSCD
北大核心
2020年第4期1137-1141,共5页
Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology
基金
海南省科学技术厅社会发展(ZDYF2018161):中医穴位注射重组人促红素改善肾性贫血效果评估,负责人:曾翠青
2019年卫生健康发展专项资金(0101217)重点专科-肾病科,负责人:谈平
关键词
微小病变肾病
水肿
中药
杨霓芝
minimal change disease
edema
Chinese medicine
Yang Nizhi
作者简介
通讯作者:通讯作者:杨霓芝,主任医师,博士研究生导师,博士后合作教授,主要研究方向:中西医结合防治肾脏病。
